Executive · Operator
Mikael Svensson
Mikael Svensson is Chief Executive Officer of SaNOtize Research and Development Corp., the Vancouver-based company commercializing nitric oxide as an antimicrobial platform, most recently through its NOWONDER consumer nasal cleanser. A chemical engineer by training with more than two decades in medical device and pharmaceutical commercialization, he previously led the global launch of INOmax inhaled nitric oxide therapy and worldwide expansion work on Restylane, Naftin, Mederma and VagiVital.